Stay updated on CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma
Sign up to get notified when there's something new on the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page.

Latest updates to the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page
- Check6 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the history list.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe record history now includes more version entries, with additions and deletions color-coded to show edits to Study Status and Contacts/Locations.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision v3.5.0 was added and Revision v3.4.3 was removed from the history list.SummaryDifference0.1%

- Check49 days agoChange DetectedThe history now includes revision v3.4.3 and excludes v3.4.2.SummaryDifference0.1%

- Check71 days agoChange DetectedA new version entry on 2026-02-09 adds updates to Study Status and Contacts/Locations, with Revision: v3.4.2. The history also shows a prior deletion entry on 2025-11-12 (Revision: v3.4.1).SummaryDifference0.4%

- Check78 days agoChange DetectedRevision history now shows an addition of Revision: v3.4.1 and removal of Revision: v3.4.0, reflecting a minor version update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma
Enter your email address, and we'll notify you when there's something new on the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page.